AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has been in talks with US regulators for months over submitting its vaccine for approval in the country, and had been expected to file with the Food and Drug Administration early last year. Those claims came amid a wider backlash against the vaccine across Europe, with the French president Emmanuel Macron branding the vaccine "quasi-ineffective" among older adults. AstraZeneca played a crucial role in the initial vaccine rollout in the UK, with its jab credited with preventing a fresh Covid wave late last year when there was a surge in cases across mainland Europe, where Pfizer and Moderna vaccines were widely used.

Covid Vaccine  abandon  astrazeneca  push  europe  submitting  expected  vaccine  trial  mene  approval  moderna  set  pfizer  head  vaccines

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
8 months ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
8 months ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

The victims of AstraZeneca's vaccine
1 year, 7 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 3 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

US: FDA authorises COVID-19 vaccines for children under 5
2 years, 6 months ago

US: FDA authorises COVID-19 vaccines for children under 5

Al Jazeera  

US President Joe Biden says jabs could be rolled out to that age group as early as next week, pending CDC approval. The US Food and Drug Administration has authorised two COVID-19 vaccines for children under five, opening the door to vaccinating millions of the country’s youngest children once the Centers for Disease Control and Prevention agrees. US President Joe …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

CDC backs Moderna COVID-19 shots after full US approval
2 years, 11 months ago

CDC backs Moderna COVID-19 shots after full US approval

Associated Press  

NEW YORK — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna’s COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval. Tens of millions of Americans have already gotten Moderna shots, following its emergency authorization by the Food and Drug Administration more than a year ago. Under earlier emergency …

US gives full approval to Moderna’s COVID-19 vaccine
2 years, 11 months ago

US gives full approval to Moderna’s COVID-19 vaccine

Associated Press  

WASHINGTON — U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of millions of Americans since its emergency authorization over a year ago. The FDA granted full approval of Pfizer’s vaccine last August. “The public can be assured that this vaccine was approved in keeping with the FDA’s rigorous …

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older
2 years, 11 months ago

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older

Daily Mail  

Moderna's COVID-19 vaccine has received full approval from the Food and Drug Administration for use in adults in the U.S., the company announced Monday. The Moderna COVID-19 vaccine has received full approval for use in adults from the FDA. Only the first two shots of Moderna's vaccine have received approval, and the booster shot remains available of the emergency use …

U.S. gives full approval to Moderna’s COVID-19 vaccine
2 years, 11 months ago

U.S. gives full approval to Moderna’s COVID-19 vaccine

LA Times  

U.S. regulators have granted full approval to Moderna’s COVID-19 vaccine after reviewing additional data on its safety and effectiveness. Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines. U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of …

Poorer nations reject over 100 million Covid shots as many close to expiry
2 years, 11 months ago

Poorer nations reject over 100 million Covid shots as many close to expiry

India Today  

Poorer nations last month rejected more than 100 million doses of Covid-19 vaccines distributed by the global programme COVAX, mainly due to their rapid expiry date, a UNICEF official said on Thursday. UNICEF's data on supplies and use of delivered vaccines show that 681 million shipped doses are currently stored in about 90 poorer nations, according to CARE, a charity, …

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?
3 years, 1 month ago

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?

ABC  

The Omicron variant has been generating anxiety across the world since being declared a COVID-19 variant of concern by the World Health Organization over the weekend. According to Westmead Institute virologist Tony Cunningham, scientists around the world — including those in Australia — would be looking at whether protective antibodies in the vaccines were "sufficiently high" to cover this strain. …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 1 month ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 2 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 3 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 3 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorize COVID antibody treatment
3 years, 3 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times  

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more
3 years, 3 months ago

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more

CNN  

CNN — Despite hopes that full approval of Pfizer’s Covid-19 vaccine would convince large numbers of vaccine-hesitant Americans to roll up their sleeves, a federal government analysis provided to CNN suggests approval was not a silver bullet. The data backs up what a recent poll found: While full approval might matter to some unvaccinated Americans, it’s likely not going to …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 3 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?
3 years, 3 months ago

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?

ABC  

When COVID-19 vaccines were being developed, manufacturers had to hit an efficacy rate of 50 per cent before their jabs could get approval. Australian National Centre for Immunisation Research and Surveillance director Kristine Macartney said it was important that people do not just look at one study or compare one study with another because, often, "the studies are done in …

AstraZeneca picks up new vaccine technology originally intended to target Covid
3 years, 3 months ago

AstraZeneca picks up new vaccine technology originally intended to target Covid

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists at Imperial College London are partnering with AstraZeneca to develop …

COVID booster use may be expanded, US health officials say
3 years, 3 months ago

COVID booster use may be expanded, US health officials say

Al Jazeera  

FDA advisory body this week recommended coronavirus booster shots for people more than age 65 and those at high risk. Top health officials in the United States have said broader approval of COVID-19 booster shots could be weeks away, after a Food and Drug Administration expert advisory panel this week recommended a third jab for a limited segment of the …

WHO, partners aim to get Africa 30% of needed doses by Feb
3 years, 3 months ago

WHO, partners aim to get Africa 30% of needed doses by Feb

Associated Press  

GENEVA — The World Health Organization and its partners said they hope to provide Africa with about 30% of the COVID-19 vaccines the continent needs by February, badly missing the 60% vaccination coverage goal that African leaders had once hoped for this year. At a press briefing Tuesday, WHO director-general Tedros Adhanom Ghebreyesus called the massive disparity in vaccination rates …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 4 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

COVID-19 vaccine program would be further behind if government focused on Pfizer, PM says
3 years, 4 months ago

COVID-19 vaccine program would be further behind if government focused on Pfizer, PM says

ABC  

The Australian COVID-19 vaccine program would be even further behind if the government had depended on Pfizer vaccines for its rollout, the Prime Minister says, as his government faces suggestions it was late to make a deal with the company. Key points: The Prime Minister says a locally made vaccine strategy has doubled the country's current vaccination rate The Prime …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 4 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Moderna completes submission for full FDA approval of Covid-19 vaccine; Pfizer seeks approval for booster dose
3 years, 4 months ago

Moderna completes submission for full FDA approval of Covid-19 vaccine; Pfizer seeks approval for booster dose

CNN  

CNN — Moderna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its Covid-19 vaccine for people age 18 and older, and Pfizer and BioNTech announced they have begun submitting data for full FDA approval of a third dose of their vaccine. Moderna has also filed with the FDA for …

What does full approval of Pfizer’s COVID-19 vaccine mean?
3 years, 4 months ago

What does full approval of Pfizer’s COVID-19 vaccine mean?

India TV News  

It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines. COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration’s emergency use authorization, which allows the agency to speed the availability of medical products during public health emergencies. Under the …

US regulators give full approval to Pfizer COVID-19 vaccine
3 years, 4 months ago

US regulators give full approval to Pfizer COVID-19 vaccine

Associated Press  

WASHINGTON — The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory. Pfizer CEO Albert Bourla called the FDA’s action “an important milestone that I think will unlock some of the more skeptical minds.” Pfizer said the …

FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine
3 years, 4 months ago

FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine

The Quint  

The United States Food and Drug Administration on Monday, 23 August, granted full approval to Pfizer-BioNTech COVID-19 vaccine, making it the first COVID-19 vaccine to move past the emergency approval status in the US. The US Food and Drug Administration's acting commissioner Janet Woocock said, "the FDA's approval of this vaccine is a milestone as we continue to battle the …

U.S. regulators give full approval to Pfizer COVID-19 vaccine
3 years, 4 months ago

U.S. regulators give full approval to Pfizer COVID-19 vaccine

LA Times  

The U.S. Food and Drug Administration has granted full approval to the Pfizer-BioNTech vaccine for people 16 and older, an endorsement that experts hope will dramatically boost vaccination rates. “The public can be very confident that this vaccine meets the high standards for safety, effectiveness and manufacturing quality the FDA requires of an approved product,” said Dr. Janet Woodcock, the …

Slew of new mandates announced after FDA grants full approval to Pfizer vaccine
3 years, 4 months ago

Slew of new mandates announced after FDA grants full approval to Pfizer vaccine

Salon  

The Food and Drug Administration on Monday officially granted full legal approval to Pfizer's COVID-19 vaccine, opening the floodgates to a slew of new vaccination mandates. Pfizer's shot, developed in conjunction with German biotechnology company BioNTech, is the first to gain full FDA approval, with Moderna and Johnson & Johnson still under authorization for emergency use. "The FDA's approval of …

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA
3 years, 4 months ago

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA

NPR  

Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA Enlarge this image toggle caption Patrick T. Fallon/AFP via Getty Images Patrick T. Fallon/AFP via Getty Images The Food and Drug Administration has formally approved Pfizer's COVID-19 vaccine. "While this and other vaccines have met the FDA's rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 4 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 4 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

AstraZeneca COVID vaccine safe for breastfeeding women, health experts say, after official advice causes confusion
3 years, 4 months ago

AstraZeneca COVID vaccine safe for breastfeeding women, health experts say, after official advice causes confusion

ABC  

When official health advice recently changed for people under 40 living in COVID-19 outbreak areas like Sydney to strongly consider getting the AstraZeneca vaccine, Sophie Hill quickly made an appointment to see her GP. "If there are breastfeeding women who want the AstraZeneca vaccine and they are getting advice that they should wait, but they perceive that the risk is …

Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine
3 years, 4 months ago

Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine

Firstpost  

The companies plan to submit the same information to European authorities in the coming weeks. Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. “The data we’ve seen to date suggest a third dose of our vaccine …

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available
3 years, 4 months ago

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available

ABC  

Young Australians in locked-down cities are rolling up their sleeves in massive numbers to protect themselves with the AstraZeneca vaccine. Unvaccinated younger workers who cannot work from home are continuing to circulate the virus in Sydney, and the NSW government is hoping higher vaccination rates will put downward pressure on the infection curve, as well as reduce the number of …

Young people explain why they are seeking out COVID-19 jabs
3 years, 5 months ago

Young people explain why they are seeking out COVID-19 jabs

ABC  

Many months after Australians first started getting coronavirus vaccines, incremental changes are enabling more young people to access the jabs. Young people getting their first dose at the vaccine hub at Carlton's Royal Exhibition Building shared some of their motivations, thoughts and hopes as they took the crucial step. "Since they allowed AstraZeneca into the state facilities I think more …

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta
3 years, 5 months ago

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta

ABC  

Back in April, the Prime Minister stood up at a late-night press conference and announced the Pfizer vaccine would be preferred over AstraZeneca for most people under 50. Key points: Two doses of AstraZeneca is 92 per cent effective against hospitalisation from the Delta variant, a UK study found Two doses of AstraZeneca is 92 per cent effective against hospitalisation …

Discover Related